astrazeneca
AstraZeneca benefits outweigh risks, EMA says as EU orders 10 million more Pfizer doses
The EU's medicines regulator said Tuesday it was "firmly convinced" the benefits of AstraZeneca's vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears. It came as Brussels sealed a deal for 10 million more Pfizer doses.
